Colgate-Palmolive (CL) Reports In-Line Q2 EPS

Colgate-Palmolive (NYSE: CL) reported Q2 EPS of $0.80, in-line with the analyst estimate of $0.80. Revenue for the quarter came in at $4.26 billion versus the consensus estimate of $4.24 billion.

Full Year 2021 Guidance:

Based on current spot rates:

• The Company still expects net sales to be up 4% to 7% including a low-single-digit benefit from foreign exchange.
• The Company still expects organic sales to be up within its long-term targeted range of 3% to 5%.
• On a GAAP basis, the Company now expects a decline in gross profit margin, increased advertising investment and earnings-per-share growth at the lower end of its low to mid-single-digit range.
• On a non-GAAP (Base Business) basis, the Company now expects a decline in gross profit margin, increased advertising investment and earnings-per-share growth at the lower end of its mid to high-single-digit range.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
• Integra Resources (ITRG) Tops Q2 EPS by 6c